Delivery Order V797D70258-75A50322F80021
Award Date 9/1/22
Potential Completion Date 8/31/23
Potential Value $3M
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2D014D0005|8002, was made by the Defense Logistics Agency's Medical Supply Chain to Heyltex Corporation, a for-profit manufacturer of goods. The contract, valued at $244,040.16, is for the delivery of Prussian Blue (Radiogardase) insoluble capsules, a pharmaceutical product used to treat radioactive material contamination. Heyltex Corporation, doing business as Heyltex Corp, is a small business that has been a key supplier of this critical medical...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $14,662.00 and an ultimate completion date of March 25, 2024. It is not a set-aside contract. The award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA. This single-award vehicle allows the DLA to issue delivery orders...
- This is a $45,053.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a medical product. The award is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Granix 480 mcg/0.8 mL in safe syringes, valued at $1,972.12. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIORIX vials. The contract has a ceiling value of $20,188.40 and a completion date of June 16, 2025. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that the...
- This delivery order, awarded July 14, 2025, represents a $3,264.03 firm fixed-price contract for Praziquantel 600 mg tablets (quantity of 6) to be delivered by August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected as the prime contractor under this non-competitive set-aside contract. The order is funded by the Defense Medical Supply Chain, a division of the Defense Department, and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Granisetron HCL 1 mg tablets in unit dose packages of 20 units, with a ceiling value of $1,526.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- This delivery order, awarded on August 20, 2025, represents a $1,002.42 firm fixed-price contract to supply Praziquantel tablets to the Defense Logistics Agency's Medical Supply Chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through open competition with no set-aside designation. Performance will be completed at the contractor's Conshohocken facility, with an ultimate completion date of August 21, 2025. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a ceiling value of $10,873.00 and a completion date of July 25, 2023. The contract is a Firm Fixed Price (FFP) Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,838.40 firm fixed-price delivery order is for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70258Federal Supply Schedule
- V797D70258-75A50322F80021Delivery Order
This delivery order, valued at $2,994,684, was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Heyltex Corporation under Federal Supply Schedule number V797D-70258 for Pharmaceuticals and Drugs. The purpose of this firm fixed price order is for Heyltex to acquire and stockpile 40,744 bottles of Prussian Blue (Radiogardase), insoluble cap, 500mg oral, National Drug Code 58060-0002-02 over a 12-month period of performance from September 1, 2022 through August 31, 2023. No information was provided regarding the use of any subcontractors by Heyltex Corporation for this delivery order.
Generated 11/27/23, 11:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 10/2/23 | |
| Not listed | Not listed | $3.0m | 8/24/22 |